Priyam Shah | Investor Relations |
Brian McKelligon | Chief Executive Officer |
John Ek | Chief Financial Officer |
Tim Chiang | Capital One |
Mason Carrico | Stephens Inc |
Ruizhi Qin | JPMorgan |
Vivian Bais | BTIG |
Kyle Mikson | Canaccord Genuity |
David Westenberg | Piper Sandler |
Lucas Baranowski | UBS |
Good day and thank you for standing by. Welcome to the Akoya Biosciences First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand it over to our first speaker.